Consumers Seek To Pause Pfizer Exit From Testosterone Suit

By Jessica Corso (December 22, 2015, 8:23 PM EST) -- Consumers claiming pharmaceutical companies failed to warn about heart problems linked to certain testosterone replacement drugs urged an Illinois federal judge Tuesday to hold off on dismissing Pfizer and an Endo unit from multidistrict litigation, arguing they should be allowed to examine evidence that the U.S. Food and Drug Administration permitted the companies to update their drug labels....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!